Concepedia

George Dover

GD

Statistics

Publications

7

Citations

1.3K

H-Index

7

Active since

1993

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

University of Maryland, Baltimore

Boston University

George Dover is an author at Johns Hopkins Medicine specializing in medicine, pharmacology, and oncology.

Publications per year

1993–2017

7

Publications

7

Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms

Steven D. Gore, Stephen B. Baylin, Elizabeth A. Sugar et al. · Cancer Research · 2006 · 472 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

Susan P. Perrine, Gordon D. Ginder, Douglas V. Faller et al. · New England Journal of Medicine · 1993 · 444 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.

Barbara A. Conley, Merrill J. Egorin, Nancy Tait et al. · PubMed · 1998 · 155 citations

Medicine, Oncology, Pharmacology +9

Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Steven D. Gore, Li-Jun Weng, William D. Figg et al. · PubMed · 2002 · 153 citations

Medicine, Pharmacology, Pharmacotherapy +14

Sustained increase in haemoglobin and RBC following long‐term administration of recombinant human erythropoietin to patients with homozygous beta‐thalassaemia

E. A. Rachmilewitz, Memet Aker, Daniel J. Perry et al. · British Journal of Haematology · 1995 · 52 citations

Medicine, Hematology, Pharmacology +11

1–5 of 7